CASE HISTORY: NURTEC® ODT (RIMEGEPANT) FOR THE ACUTE AND PREVENTIVE TREATMENT OF MIGRAINE

ADVERTISEMENT RETURN TO BOOKPREVChapterNEXTCASE HISTORY: NURTEC® ODT (RIMEGEPANT) FOR THE ACUTE AND PREVENTIVE TREATMENT OF MIGRAINEGene M. DubowchikGene M. DubowchikBiohaven Pharmaceuticals, New Haven, Connecticut, U.S.AMore by Gene M. Dubowchik, Robert CroopRobert CroopBiohaven Pharmaceuticals, New Haven, Connecticut, U.S.AMore by Robert Croop, and Charles M. ConwayCharles M. ConwayBiohaven Pharmaceuticals, New Haven, Connecticut, U.S.AMore by Charles M. ConwayDOI: 10.1021/mc-2022-vol57.ch21Publication Date (Web):December 21, 2022Publication History Published online21 December 2022Request reuse permissions Copyright © 2022 MEDI, Inc. Published by American Chemical Society.2022 Medicinal Chemistry ReviewsChapter 21pp 517-542Medicinal Chemistry ReviewsVol. 57ISBN13: 9781734427455eISBN: 9781734427455Article Views220Altmetric-Citations-LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit Read OnlinePDF (1 MB) Get e-Alerts